title: Pharmacokinetics of oral terbinafine in adult horses.
abstract: The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o. terbinafine administered with p.o. cimetidine in healthy adult horses. The second objective was to assess the pharmacokinetics of terbinafine when administered per rectum in two different suspensions at 30 mg/kg to adult horses. Six healthy adult horses were included in this crossover study. Plasma terbinafine concentrations were quantified with liquid chromatography and mass spectrometry. The half-life (geometric mean) was 8.38 and 10.76 h, for p.o. alone and p.o. with cimetidine, respectively. The mean maximum plasma concentrations were 0.291 μg/mL at 1.54 h and 0.418 μg/mL at 1.28 h for p.o. alone and p.o. with cimetidine, respectively. Terbinafine with cimetidine had an average CMAX44% higher and the relative F was 153% compared p.o. terbinafine alone, but was not statistically different (P > 0.05). Terbinafine was infrequently detected when administered per rectum in two different suspensions (water or olive oil). Minor adverse effects included oral irritation, fever, and colic. All resolved spontaneously. More pharmacokinetic studies are indicated assessing drug-drug interactions and using multiple dosing intervals to improve our knowledge of effective oral dosing, the potential for drug accumulation, and systemic adverse effect of terbinafine in horses.
authors.affiliation: Department of Clinical Sciences, Veterinary Health Center, Kansas State University, Manhattan, KS, USA.
authors.forename: T J
authors.initials: TJ
authors.lastname: Younkin
authors.affiliation: Department of Clinical Sciences, Veterinary Health Center, Kansas State University, Manhattan, KS, USA.
authors.forename: E G
authors.initials: EG
authors.lastname: Davis
authors.affiliation: Department of Anatomy and Physiology, Institute of Computational Comparative Medicine, Kansas State University, Manhattan, KS, USA.
authors.forename: B
authors.initials: B
authors.lastname: Kukanich
mesh_terms: D000284:Administration, Oral; D000818:Animals; D019540:Area Under Curve; D002927:Cimetidine / Q000493:pharmacokinetics*; D018592:Cross-Over Studies; D004347:Drug Interactions; D004357:Drug Synergism; D006207:Half-Life; D006736:Horses / Q000378:metabolism*; D009281:Naphthalenes / Q000493:pharmacokinetics*; D000077291:Terbinafine
chemical_list: D009281:Naphthalenes; D002927:Cimetidine; D000077291:Terbinafine